RE:RE:RE:RE:RE:Italy
Wino115 wrote: I think we can go with Paul's "...it was a good price..." ! Certainly not US levels, but probably not below 50%. It had always sounded to me like they thought they could get 75-80% of US price and the Viiv product provided a bit of an umbrella to that as well.
SPCEO1 wrote: I think I will need to hire an Italian lawyer to actually figure out what the annual revenues from one Italian patient on Trogarzo for a year might be! They also mentioned discounts but it is not clear to me what those discounts might be and there seemed to be other circumstances that might impact the price. But figuring all that out seems like a lot of work and that you need to know someone familiar with Italian drug pricing to get an accurate answer.
scarlet1967 wrote: "packaging: «200 mg - concentrate for solution for infusion -
intravenous use - vial (glass) - 1.33 ml (150 mg / ml) »2
vials - AIC n. 048255018 / E (base 10);
reimbursement class: H;
ex factory price (excluding VAT): euro 2,000.00;
retail price (VAT included): € 3,300.80.”
I don’t know what the reimbursement H class means versus retail price but 2000 euros equals US $2328. Compared with the US pricing excluding VAT(tax in Italy 22%) it seems it’s about 13% cheaper in Italy.
“The cost for Trogarzo intravenous solution (200 mg/1.33 mL) is around $2,671 for a supply of 2.66 milliliters.
The annual list price for every two-week infusions is $118,000.”